We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

How the Immune System Reacts to Malaria and Sickle Cell Disease content piece image
News

How the Immune System Reacts to Malaria and Sickle Cell Disease

Scientists have discovered in more detail than ever before how the human body’s immune system reacts to malaria and sickle cell disease. This sheds light on how abnormal red blood cells are recognized and cleared by the immune system and opens therapeutic avenues.
Fermented Milk's Impact on Gut Microbes Could Help To Lower Blood Pressure content piece image
News

Fermented Milk's Impact on Gut Microbes Could Help To Lower Blood Pressure

In recent years, fermented dairy foods have been gaining attention for their health benefits. Recent work indicates that, through their action on the gut microbiome, these foods could help reduce conditions like hypertension (high blood pressure).
The Secret to Precisely Turning Genes On and Off content piece image
News

The Secret to Precisely Turning Genes On and Off

In a recent study, scientists have shown how to simultaneously harness multiple forms of regulation in living cells to strictly control gene expression and open new avenues for improved biotechnologies.
Oxford⁠–AstraZeneca Vaccine Is Safe and Highly Effective, Phase III Study Finds content piece image
News

Oxford⁠–AstraZeneca Vaccine Is Safe and Highly Effective, Phase III Study Finds

A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective, adding to previous trial data from the United Kingdom, Brazil and South Africa, as well as real-world impact data from the United Kingdom.
Immune Cells That Contribute to Transplant Rejection Identified content piece image
News

Immune Cells That Contribute to Transplant Rejection Identified

Non-circulating memory T cells, whose main function is to provide local protection against re-infection, contribute to chronic transplant rejection, University of Pittsburgh School of Medicine researchers reveal.
Oxford–AstraZeneca Vaccine Not Associated With Overall Risk of Thromboembolic Events, Says EMA content piece image
News

Oxford–AstraZeneca Vaccine Not Associated With Overall Risk of Thromboembolic Events, Says EMA

The European Medicines Agency (EMA)'s Pharmacovigilance Risk Assessment Committee (PRAC) has shared a statement after concluding its review of the Oxford–AstraZeneca COVID-19 vaccine following reports of thromboembolic events occurring in a small number people.
New Study Provides Global Analysis of COVID-19 Vaccines content piece image
News

New Study Provides Global Analysis of COVID-19 Vaccines

A new study has compared twelve COVID-19 vaccines that had initiated or announced the Phase III clinical trial stage by early November 2020. The study highlights the early successes, as well as the hurdles and barriers yet to be overcome for ending the global COVID-19 pandemic.
Tool Helps To Catch Potentially Fatal Pig Disease Early content piece image
News

Tool Helps To Catch Potentially Fatal Pig Disease Early

Researchers have developed a diagnostic test that can identify virulent forms of the swine bacterial pathogen Streptococcus equi subspecies zooepidemicus which can cause severe illness and death in pigs, other animals and rarely people.
How Inflammation Leads to Bone Erosion content piece image
News

How Inflammation Leads to Bone Erosion

In a study investigating the mechanism that exacerbates rheumatoid arthritis in smokers, researchers have discovered a novel path in the inflammatory process associated with the bone damage caused by rheumatoid arthritis. The discovery opens up opportunities for new therapeutic interventions for the disease.
Programming CAR T Cells so That They Only Kill Cancer Cells content piece image
News

Programming CAR T Cells so That They Only Kill Cancer Cells

A study recently published in the Science journal has found a solution to applying CAR T cell therapy to solid tumours: programming CAR T cells so that they only kill cancer cells, leaving alone healthy cells that have the same marker protein as cancer cells.
Advertisement